Which has better earnings & valuation, ESNT or IOF?

Iofina has lower revenue, but higher earnings than Essentra. Iofina is trading at a lower price-to-earnings ratio than Essentra, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Essentra £302M 0.81 £3.50M £0.70 122.43 Iofina £66.52M 1.28 £4.28M £4.00 11.13

Is ESNT or IOF more profitable?

Iofina has a net margin of 11.84% compared to Essentra's net margin of 0.70%. Iofina's return on equity of 14.89% beat Essentra's return on equity. Company Net Margins Return on Equity Return on Assets Essentra 0.70% 0.79% 1.74% Iofina 11.84% 14.89% 5.18%

Which has higher earnings & valuation, IOF or ZTF?

Zotefoams has higher revenue and earnings than Iofina. Zotefoams is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Iofina £66.52M 1.28 £4.28M £4.00 11.13 Zotefoams £158.49M 1.33 £9.80M £44.87 9.60

Is IOF or ZTF more profitable?

Zotefoams has a net margin of 14.28% compared to Iofina's net margin of 11.84%. Zotefoams' return on equity of 18.25% beat Iofina's return on equity. Company Net Margins Return on Equity Return on Assets Iofina 11.84% 14.89% 5.18% Zotefoams 14.28% 18.25% 5.48%

Which has preferable earnings & valuation, IOF or TET?

Treatt has higher revenue and earnings than Iofina. Iofina is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Iofina £66.52M 1.28 £4.28M £4.00 11.13 Treatt £128.29M 1.39 £11.22M £7.22 41.83

Is IOF or TET more profitable?

Iofina has a net margin of 11.84% compared to Treatt's net margin of 3.40%. Iofina's return on equity of 14.89% beat Treatt's return on equity. Company Net Margins Return on Equity Return on Assets Iofina 11.84% 14.89% 5.18% Treatt 3.40% 3.22% 6.72%

Which has stronger earnings & valuation, IOF or SYNT?

Iofina has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Iofina £66.52M 1.28 £4.28M £4.00 11.13 Synthomer £1.74B 0.10 -£82.04M -£96.00 N/A

Is IOF or SYNT more profitable?

Iofina has a net margin of 11.84% compared to Synthomer's net margin of -9.03%. Iofina's return on equity of 14.89% beat Synthomer's return on equity. Company Net Margins Return on Equity Return on Assets Iofina 11.84% 14.89% 5.18% Synthomer -9.03% -16.66% -0.28%

Do analysts recommend HDD or IOF?

Iofina has a consensus target price of GBX 60, indicating a potential upside of 34.79%. Given Iofina's stronger consensus rating and higher probable upside, analysts plainly believe Iofina is more favorable than Hardide. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hardide 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Iofina 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00

Which has better valuation and earnings, HDD or IOF?

Iofina has higher revenue and earnings than Hardide. Iofina is trading at a lower price-to-earnings ratio than Hardide, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hardide £6.03M 8.95 -£1.89M £0.20 342.50 Iofina £66.52M 1.28 £4.28M £4.00 11.13

Is HDD or IOF more profitable?

Hardide has a net margin of 15.60% compared to Iofina's net margin of 11.84%. Hardide's return on equity of 32.49% beat Iofina's return on equity. Company Net Margins Return on Equity Return on Assets Hardide 15.60% 32.49% -9.80% Iofina 11.84% 14.89% 5.18%

Iofina (IOF) Competitors

GBX 44.52 -0.49 (-1.08%)

As of 04:28 AM Eastern

Compare

IOF vs. ESNT, ZTF, TET, SYNT, and HDD

Should you buy Iofina stock or one of its competitors? MarketBeat compares Iofina with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Iofina include Essentra (ESNT), Zotefoams (ZTF), Treatt (TET), Synthomer (SYNT), and Hardide (HDD). These companies are all part of the "specialty chemicals" industry.

How does Iofina compare to Essentra?

Essentra (LON:ESNT) and Iofina (LON:IOF) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, media sentiment, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations.

Iofina has a net margin of 11.84% compared to Essentra's net margin of 0.70%. Iofina's return on equity of 14.89% beat Essentra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Essentra	0.70%	0.79%	1.74%
Iofina	11.84%	14.89%	5.18%

In the previous week, Essentra had 1 more articles in the media than Iofina. MarketBeat recorded 1 mentions for Essentra and 0 mentions for Iofina. Essentra's average media sentiment score of 0.75 beat Iofina's score of 0.00 indicating that Essentra is being referred to more favorably in the media.

Company	Overall Sentiment
Essentra	Positive
Iofina	Neutral

Essentra has a beta of 0.802, suggesting that its share price is 20% less volatile than the broader market. Comparatively, Iofina has a beta of 0.854, suggesting that its share price is 15% less volatile than the broader market.

Essentra presently has a consensus target price of GBX 150, indicating a potential upside of 75.03%. Iofina has a consensus target price of GBX 60, indicating a potential upside of 34.79%. Given Essentra's higher possible upside, equities analysts clearly believe Essentra is more favorable than Iofina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Essentra	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

69.5% of Essentra shares are owned by institutional investors. Comparatively, 2.5% of Iofina shares are owned by institutional investors. 0.5% of Essentra shares are owned by company insiders. Comparatively, 13.4% of Iofina shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Iofina has lower revenue, but higher earnings than Essentra. Iofina is trading at a lower price-to-earnings ratio than Essentra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Essentra	£302M	0.81	£3.50M	£0.70	122.43
Iofina	£66.52M	1.28	£4.28M	£4.00	11.13

Summary

Iofina beats Essentra on 9 of the 16 factors compared between the two stocks.

How does Iofina compare to Zotefoams?

Iofina (LON:IOF) and Zotefoams (LON:ZTF) are both small-cap basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, risk, analyst recommendations, earnings and media sentiment.

2.5% of Iofina shares are held by institutional investors. Comparatively, 29.5% of Zotefoams shares are held by institutional investors. 13.4% of Iofina shares are held by insiders. Comparatively, 4.5% of Zotefoams shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Iofina presently has a consensus price target of GBX 60, suggesting a potential upside of 34.79%. Zotefoams has a consensus price target of GBX 605, suggesting a potential upside of 40.45%. Given Zotefoams' higher possible upside, analysts clearly believe Zotefoams is more favorable than Iofina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Zotefoams has higher revenue and earnings than Iofina. Zotefoams is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Iofina	£66.52M	1.28	£4.28M	£4.00	11.13
Zotefoams	£158.49M	1.33	£9.80M	£44.87	9.60

Iofina has a beta of 0.854, suggesting that its stock price is 15% less volatile than the broader market. Comparatively, Zotefoams has a beta of 1.255, suggesting that its stock price is 26% more volatile than the broader market.

In the previous week, Zotefoams had 1 more articles in the media than Iofina. MarketBeat recorded 1 mentions for Zotefoams and 0 mentions for Iofina. Zotefoams' average media sentiment score of 0.55 beat Iofina's score of 0.00 indicating that Zotefoams is being referred to more favorably in the news media.

Company	Overall Sentiment
Iofina	Neutral
Zotefoams	Positive

Zotefoams has a net margin of 14.28% compared to Iofina's net margin of 11.84%. Zotefoams' return on equity of 18.25% beat Iofina's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Iofina	11.84%	14.89%	5.18%
Zotefoams	14.28%	18.25%	5.48%

Summary

Zotefoams beats Iofina on 13 of the 15 factors compared between the two stocks.

How does Iofina compare to Treatt?

Iofina (LON:IOF) and Treatt (LON:TET) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, profitability, valuation, media sentiment, dividends and risk.

Iofina has a net margin of 11.84% compared to Treatt's net margin of 3.40%. Iofina's return on equity of 14.89% beat Treatt's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Iofina	11.84%	14.89%	5.18%
Treatt	3.40%	3.22%	6.72%

2.5% of Iofina shares are owned by institutional investors. Comparatively, 17.4% of Treatt shares are owned by institutional investors. 13.4% of Iofina shares are owned by insiders. Comparatively, 4.1% of Treatt shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Treatt has higher revenue and earnings than Iofina. Iofina is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Iofina	£66.52M	1.28	£4.28M	£4.00	11.13
Treatt	£128.29M	1.39	£11.22M	£7.22	41.83

Iofina has a beta of 0.854, meaning that its share price is 15% less volatile than the broader market. Comparatively, Treatt has a beta of 0.909, meaning that its share price is 9% less volatile than the broader market.

Iofina presently has a consensus price target of GBX 60, suggesting a potential upside of 34.79%. Treatt has a consensus price target of GBX 248.33, suggesting a potential downside of 17.77%. Given Iofina's stronger consensus rating and higher probable upside, equities analysts plainly believe Iofina is more favorable than Treatt.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Treatt	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, Treatt had 3 more articles in the media than Iofina. MarketBeat recorded 3 mentions for Treatt and 0 mentions for Iofina. Treatt's average media sentiment score of 0.02 beat Iofina's score of 0.00 indicating that Treatt is being referred to more favorably in the news media.

Company	Overall Sentiment
Iofina	Neutral
Treatt	Neutral

Summary

Treatt beats Iofina on 10 of the 15 factors compared between the two stocks.

How does Iofina compare to Synthomer?

Iofina (LON:IOF) and Synthomer (LON:SYNT) are both small-cap basic materials companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation, risk and media sentiment.

Iofina has a net margin of 11.84% compared to Synthomer's net margin of -9.03%. Iofina's return on equity of 14.89% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Iofina	11.84%	14.89%	5.18%
Synthomer	-9.03%	-16.66%	-0.28%

Iofina presently has a consensus price target of GBX 60, suggesting a potential upside of 34.79%. Synthomer has a consensus price target of GBX 86.75, suggesting a potential downside of 21.22%. Given Iofina's stronger consensus rating and higher probable upside, analysts clearly believe Iofina is more favorable than Synthomer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Synthomer	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

2.5% of Iofina shares are held by institutional investors. Comparatively, 19.9% of Synthomer shares are held by institutional investors. 13.4% of Iofina shares are held by company insiders. Comparatively, 5.0% of Synthomer shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Iofina has a beta of 0.854, indicating that its stock price is 15% less volatile than the broader market. Comparatively, Synthomer has a beta of 0.922, indicating that its stock price is 8% less volatile than the broader market.

Iofina has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Iofina	£66.52M	1.28	£4.28M	£4.00	11.13
Synthomer	£1.74B	0.10	-£82.04M	-£96.00	N/A

In the previous week, Synthomer had 1 more articles in the media than Iofina. MarketBeat recorded 1 mentions for Synthomer and 0 mentions for Iofina. Iofina's average media sentiment score of 0.00 equaled Synthomer'saverage media sentiment score.

Company	Overall Sentiment
Iofina	Neutral
Synthomer	Neutral

Summary

Iofina beats Synthomer on 11 of the 15 factors compared between the two stocks.

How does Iofina compare to Hardide?

Hardide (LON:HDD) and Iofina (LON:IOF) are both small-cap basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk.

Hardide has a beta of 0.972, suggesting that its stock price is 3% less volatile than the broader market. Comparatively, Iofina has a beta of 0.854, suggesting that its stock price is 15% less volatile than the broader market.

Hardide has a net margin of 15.60% compared to Iofina's net margin of 11.84%. Hardide's return on equity of 32.49% beat Iofina's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hardide	15.60%	32.49%	-9.80%
Iofina	11.84%	14.89%	5.18%

10.2% of Hardide shares are owned by institutional investors. Comparatively, 2.5% of Iofina shares are owned by institutional investors. 65.7% of Hardide shares are owned by company insiders. Comparatively, 13.4% of Iofina shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Iofina has higher revenue and earnings than Hardide. Iofina is trading at a lower price-to-earnings ratio than Hardide, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hardide	£6.03M	8.95	-£1.89M	£0.20	342.50
Iofina	£66.52M	1.28	£4.28M	£4.00	11.13

Iofina has a consensus target price of GBX 60, indicating a potential upside of 34.79%. Given Iofina's stronger consensus rating and higher probable upside, analysts plainly believe Iofina is more favorable than Hardide.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hardide	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, Hardide's average media sentiment score of 0.32 beat Iofina's score of 0.00 indicating that Hardide is being referred to more favorably in the media.

Company	Overall Sentiment
Hardide	Neutral
Iofina	Neutral

Summary

Hardide beats Iofina on 8 of the 15 factors compared between the two stocks.

Get Iofina News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IOF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IOF vs. The Competition

Export

Metric	Iofina	Specialty Chemicals Industry	Materials Sector	LON Exchange
Market Cap	£85.41M	£8.26B	£4.95B	£2.78B
Dividend Yield	2.88%	3.37%	4.95%	6.13%
P/E Ratio	11.13	19.99	23.42	364.69
Price / Sales	1.28	125.04	6,554.89	87,589.47
Price / Cash	7.96	19.25	27.43	27.85
Price / Book	1.98	3.42	9.42	7.72
Net Income	£4.28M	£213.62M	£156.62M	£5.89B
7 Day Performance	-8.03%	0.50%	-0.51%	0.13%
1 Month Performance	N/A	N/A	17.05%	N/A
1 Year Performance	78.06%	33.75%	68.60%	74.58%

Iofina Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IOF Iofina	2.3355 of 5 stars	GBX 44.52 -1.1%	GBX 60 +34.8%	+85.2%	£85.41M	£66.52M	11.13	95
ESNT Essentra	4.3933 of 5 stars	GBX 87.10 +3.1%	GBX 150 +72.2%	-11.8%	£240.09M	£302M	124.43	350
ZTF Zotefoams	4.5147 of 5 stars	GBX 396.84 +1.0%	GBX 605 +52.5%	+42.8%	£193.28M	£158.49M	8.84	549
TET Treatt	0.7165 of 5 stars	GBX 301.03 +0.0%	GBX 248.33 -17.5%	+10.8%	£177.70M	£128.29M	41.69	350	News Coverage
SYNT Synthomer	1.1979 of 5 stars	GBX 106.80 +6.6%	GBX 86.75 -18.8%	+2.8%	£164.27M	£1.74B	N/A	4,200

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:IOF) was last updated on 6/4/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Iofina (IOF) Competitors